Rashi Khanna-Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Rashi Khanna-Jain has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Annukka Vuorinen
REGEA, Institute for Regenerative Medicine, University of Tampere and Tampere University Hospital, Biokatu-12, 33520 Tampere, Finland
2 shared publicationsRiitta Suuronen
Department of Biomedical Engineering, Tampere University of Technology, Finland
2 shared publications- Susanna Miettinen
Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2 shared publications - George K. B. Sandor
Department of Oral and Maxillofacial Surgery, Oulu University Hospital and Medical Research Center, University of Oulu, 90014 Oulu, Finland
1 shared publication George K. B. Sándor
1 shared publicationHideki Agata
Regea Institute for Regenerative Medicine, University of Tampere and Tampere University Hospital, Biokatu 12, 33520, Tampere, Finland
1 shared publication
Latest Publications
- 1 October 2010
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 122 (4) , 133-141
Vitamin D3 metabolites induce osteogenic differentiation in human dental pulp and human dental follicle cells
- 1 October 2010
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 122 (4) , 133-141
Vitamin D3 metabolites induce osteogenic differentiation in human dental pulp and human dental follicle cells
- 23 June 2010
- Published by Taylor & Francis in Growth Factors
- Vol. 28 (6) , 437-446
Addition of BMP-2 or BMP-6 to dexamethasone, ascorbic acid, and β-glycerophosphate may not enhance osteogenic differentiation of human periodontal ligament cells
This study was designed to investigate the potential merits of the combined use of bone morphogenetic protein (BMP)-2 or BMP-6 and osteogenic supplements (OS) [dexamethasone, ascorbic acid (AA), and β-glycerophosphate] on osteogenic differentiation of periodontal ligament cells (PDLCs). Osteogenic differentiation was evaluated by quantitative alkaline phosphatase (ALP) assay, alizarin red staining, quantitative calcium assay, and the qRT-PCR analysis for the expression of collagen type I, runt-related transcription factor-2, osteopontin (OPN), and osteocalcin in PDLCs. Culture with BMP-2 or BMP-6+AA increased ALP activity of PDLCs, suggesting their osteo-inductive effects. However, longer duration of culture showed neither of the BMPs induced in vitro mineralization. In contrast, OS were able to increase ALP activity and OPN expressions, and also induced in vitro mineralization. The mineralization ability was not enhanced by the addition of BMP-2 or BMP-6. These findings suggest that the addition of BMP-2 or BMP-6 to OS may not enhance an osteogenic differentiation of hPDLCs.
- 23 June 2010
- Published by Taylor & Francis in Growth Factors
- Vol. 28 (6) , 437-446
Addition of BMP-2 or BMP-6 to dexamethasone, ascorbic acid, and β-glycerophosphate may not enhance osteogenic differentiation of human periodontal ligament cells
This study was designed to investigate the potential merits of the combined use of bone morphogenetic protein (BMP)-2 or BMP-6 and osteogenic supplements (OS) [dexamethasone, ascorbic acid (AA), and β-glycerophosphate] on osteogenic differentiation of periodontal ligament cells (PDLCs). Osteogenic differentiation was evaluated by quantitative alkaline phosphatase (ALP) assay, alizarin red staining, quantitative calcium assay, and the qRT-PCR analysis for the expression of collagen type I, runt-related transcription factor-2, osteopontin (OPN), and osteocalcin in PDLCs. Culture with BMP-2 or BMP-6+AA increased ALP activity of PDLCs, suggesting their osteo-inductive effects. However, longer duration of culture showed neither of the BMPs induced in vitro mineralization. In contrast, OS were able to increase ALP activity and OPN expressions, and also induced in vitro mineralization. The mineralization ability was not enhanced by the addition of BMP-2 or BMP-6. These findings suggest that the addition of BMP-2 or BMP-6 to OS may not enhance an osteogenic differentiation of hPDLCs.